Plasmodium falciparum malaria, unspecified
ICD-10 B52.9 is a billable code used to indicate a diagnosis of plasmodium falciparum malaria, unspecified.
Plasmodium falciparum malaria is a severe form of malaria caused by the Plasmodium falciparum parasite, which is transmitted to humans through the bite of infected Anopheles mosquitoes. This species is responsible for the majority of malaria-related morbidity and mortality worldwide. Symptoms typically include fever, chills, headache, nausea, vomiting, and muscle pain. In severe cases, it can lead to complications such as cerebral malaria, anemia, and multi-organ failure. The unspecified designation indicates that the specific clinical manifestations or severity of the malaria infection have not been documented. Accurate identification of the species is crucial for treatment, as Plasmodium falciparum is known for its potential resistance to common antimalarial medications, necessitating careful selection of therapeutic agents. Prophylaxis is recommended for travelers to endemic areas, with medications such as atovaquone-proguanil, doxycycline, or mefloquine being commonly prescribed to prevent infection. Understanding the epidemiology, clinical presentation, and treatment options for Plasmodium falciparum malaria is essential for effective management and coding.
Detailed clinical notes on symptoms, travel history, and laboratory results.
Patients presenting with fever and travel history to endemic areas.
Ensure accurate species identification and document any resistance patterns.
Documentation of pre-travel consultations, prophylaxis prescribed, and post-travel evaluations.
Travelers returning from endemic regions with febrile illness.
Emphasize the importance of prophylaxis adherence and education on symptoms.
Used for rapid diagnosis of malaria in patients presenting with fever.
Document the reason for testing and results.
Infectious disease specialists should ensure accurate interpretation of results.
Specifying the malaria species is crucial for determining the appropriate treatment and understanding the potential for complications and drug resistance.
